Related references
Note: Only part of the references are listed.Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children: Executive Summary
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Initial Vancomycin Dosing in Pediatric Oncology and Stem Cell Transplant Patients
Christina C. Piro et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2009)
Current Recommended Dosing of Vancomycin for Children With Invasive Methicillin-Resistant Staphylococcus aureus Infections Is Inadequate
Adam Frymoyer et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
M. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin
T. P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity
Thomas P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections -: Efficacy and toxicity
Levita K. Hidayat et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Share Paper
